{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:24:19Z","timestamp":1790742259170,"version":"4.1.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T00:00:00Z","timestamp":1732320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T00:00:00Z","timestamp":1732320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2023-1156"],"award-info":[{"award-number":["RS-2023-1156"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"name":"korea, ICT and future planning","award":["2020R1A2C1008826"],"award-info":[{"award-number":["2020R1A2C1008826"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"DOI":"10.1186\/s12935-024-03569-x","type":"journal-article","created":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T05:08:11Z","timestamp":1732338491000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Enhancing antitumor immunity in Lewis lung cancer through plasma-treated medium-induced activation of dendritic cells"],"prefix":"10.1186","volume":"24","author":[{"given":"Chae Bok","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hei Gwon","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sintayehu Kebede","family":"Gurmessa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In-Taek","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naresh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongyou","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagendra Kumar","family":"Kaushik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hwa-Jung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,23]]},"reference":[{"key":"3569_CR1","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1038\/s41467-021-22801-0","volume":"12","author":"F Wu","year":"2021","unstructured":"Wu F, Fan J, He Y, Xiong A, Yu J, Li Y, et al. Single-cell profiling of tumor heterogeneity and the microenvironment in advanced non-small cell lung cancer. Nat Commun. 2021;12:2540.","journal-title":"Nat Commun"},{"key":"3569_CR2","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/nrc3775","volume":"14","author":"Z Chen","year":"2014","unstructured":"Chen Z, Fillmore CM, Hammerman PS, Kim CF, Wong K-K. Non-small-cell lung cancers: a heterogeneous set of diseases. Nat Rev Cancer. 2014;14:535\u201346.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"3569_CR3","first-page":"177","volume":"4","author":"J Domagala-Kulawik","year":"2015","unstructured":"Domagala-Kulawik J. The role of the immune system in non-small cell lung carcinoma and potential for therapeutic intervention. Translational lung cancer Res. 2015;4(2):177.","journal-title":"Translational lung cancer Res"},{"key":"3569_CR4","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.3390\/cells11203183","volume":"11","author":"T Katopodi","year":"2022","unstructured":"Katopodi T, Petanidis S, Charalampidis C, Chatziprodromidou I, Eskitzis P, Tsavlis D, et al. Tumor-infiltrating dendritic cells: decisive roles in cancer immunosurveillance, immunoediting, and tumor T cell tolerance. Cells. 2022;11:3183.","journal-title":"Cells"},{"issue":"12","key":"3569_CR5","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.it.2016.09.006","volume":"37","author":"A Gardner","year":"2016","unstructured":"Gardner A, Ruffell B. Dendritic cells and cancer immunity. Trends Immunol. 2016;37(12):855\u201365.","journal-title":"Trends Immunol"},{"key":"3569_CR6","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s00262-016-1820-y","volume":"65","author":"J Zong","year":"2016","unstructured":"Zong J, Keskinov AA, Shurin GV, Shurin MR. Tumor-derived factors modulating dendritic cell function. Cancer Immunol Immunother. 2016;65:821\u201333.","journal-title":"Cancer Immunol Immunother"},{"key":"3569_CR7","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.it.2016.09.006","volume":"37","author":"A Gardner","year":"2016","unstructured":"Gardner A, Ruffell B. Dendritic cells and cancer immunity. Trends Immunol. 2016;37:855\u201365.","journal-title":"Trends Immunol"},{"key":"3569_CR8","doi-asserted-by":"publisher","first-page":"15977","DOI":"10.18632\/oncotarget.13304","volume":"8","author":"D Yan","year":"2017","unstructured":"Yan D, Sherman JH, Keidar M. Cold atmospheric plasma, a novel promising anticancer treatment modality. Oncotarget. 2017;8:15977.","journal-title":"Oncotarget"},{"key":"3569_CR9","doi-asserted-by":"publisher","first-page":"12881","DOI":"10.1039\/C9CP00647H","volume":"21","author":"P Heirman","year":"2019","unstructured":"Heirman P, Van Boxem W, Bogaerts A. Reactivity and stability of plasma-generated oxygen and nitrogen species in buffered water solution: a computational study. Phys Chem Chem Phys. 2019;21:12881\u201394.","journal-title":"Phys Chem Chem Phys"},{"key":"3569_CR10","doi-asserted-by":"publisher","first-page":"423001","DOI":"10.1088\/1361-6463\/ab31c1","volume":"52","author":"M Khalili","year":"2019","unstructured":"Khalili M, Daniels L, Lin A, Krebs FC, Snook AE, Bekeschus S, et al. Non-thermal plasma-induced immunogenic cell death in cancer. J Phys D. 2019;52:423001.","journal-title":"J Phys D"},{"key":"3569_CR11","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.freeradbiomed.2014.11.014","volume":"79","author":"T Adachi","year":"2015","unstructured":"Adachi T, Tanaka H, Nonomura S, Hara H, Kondo S, Hori M. Plasma-activated medium induces A549 cell injury via a spiral apoptotic cascade involving the mitochondrial-nuclear network. Free Radic Biol Med. 2015;79:28\u201344.","journal-title":"Free Radic Biol Med"},{"issue":"4","key":"3569_CR12","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s11090-023-10330-1","volume":"43","author":"P Poramapijitwat","year":"2023","unstructured":"Poramapijitwat P, Thana P, Sukum P, Liangdeng Y, Kuensaen C, Boonyawan D. Selective cytotoxicity of lung cancer cells\u2014A549 and H1299\u2014Induced by ringer\u2019s lactate solution activated by a non-thermal air plasma jet device, Nightingale\u00ae. Plasma Chem Plasma Process. 2023;43(4):805\u201330.","journal-title":"Plasma Chem Plasma Process"},{"key":"3569_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cpme.2018.06.001","volume":"11","author":"S Bekeschus","year":"2018","unstructured":"Bekeschus S, Scherwietes L, Freund E, Liedtke KR, Hackbarth C, von Woedtke T, et al. Plasma-treated medium tunes the inflammatory profile in murine bone marrow-derived macrophages. Clin Plasma Med. 2018;11:1\u20139.","journal-title":"Clin Plasma Med"},{"key":"3569_CR14","doi-asserted-by":"publisher","first-page":"116657","DOI":"10.1016\/j.biopha.2024.116657","volume":"175","author":"C Chen","year":"2024","unstructured":"Chen C, Zhou S, Yang X, Ren M, Qi Y, Mao Y, et al. In vitro study of cold atmospheric plasma-activated liquids inhibits malignant melanoma by affecting macrophage polarization through the ROS\/JAK2\/STAT1 pathway. Biomed Pharmacother. 2024;175:116657.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"3569_CR15","doi-asserted-by":"publisher","first-page":"4099","DOI":"10.1038\/s41598-019-40637-z","volume":"9","author":"A Azzariti","year":"2019","unstructured":"Azzariti A, Iacobazzi RM, Di Fonte R, Porcelli L, Gristina R, Favia P, et al. Plasma-activated medium triggers cell death and the presentation of immune activating danger signals in melanoma and pancreatic cancer cells. Sci Rep. 2019;9(1):4099.","journal-title":"Sci Rep"},{"key":"3569_CR16","doi-asserted-by":"publisher","first-page":"109051","DOI":"10.1016\/j.jnutbio.2022.109051","volume":"107","author":"L Yan","year":"2022","unstructured":"Yan L, Sundaram S, Rust BM, Picklo MJ, Bukowski MR. Metabolomes of Lewis lung carcinoma metastases and normal lung tissue from mice fed different diets. J Nutr Biochem. 2022;107:109051.","journal-title":"J Nutr Biochem"},{"issue":"1","key":"3569_CR17","doi-asserted-by":"publisher","first-page":"18154","DOI":"10.1038\/s41598-020-75214-2","volume":"10","author":"Y-J Cheng","year":"2020","unstructured":"Cheng Y-J, Lin C-K, Chen C-Y, Chien P-C, Chuan H-H, Ho C-C, et al. Plasma-activated medium as adjuvant therapy for lung cancer with malignant pleural effusion. Sci Rep. 2020;10(1):18154.","journal-title":"Sci Rep"},{"key":"3569_CR18","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/s41598-018-37169-3","volume":"9","author":"E Freund","year":"2019","unstructured":"Freund E, Liedtke KR, van der Linde J, Metelmann H-R, Heidecke C-D, Partecke L-I, et al. Physical plasma-treated saline promotes an immunogenic phenotype in CT26 colon cancer cells in vitro and in vivo. Sci Rep. 2019;9:634.","journal-title":"Sci Rep"},{"issue":"2","key":"3569_CR19","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nri.2016.107","volume":"17","author":"L Galluzzi","year":"2017","unstructured":"Galluzzi L, Buqu\u00e9 A, Kepp O, Zitvogel L, Kroemer G. Immunogenic cell death in cancer and infectious disease. Nat Rev Immunol. 2017;17(2):97\u2013111.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"3569_CR20","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1387\/ijdb.150061pa","volume":"59","author":"A Garg","year":"2015","unstructured":"Garg A, Dudek-Peric AM, Romano E, Agostinis P. Immunogenic cell death. Int J Dev Biol. 2015;59(1):131\u201340.","journal-title":"Int J Dev Biol"},{"key":"3569_CR21","doi-asserted-by":"publisher","first-page":"122189","DOI":"10.1016\/j.biomaterials.2023.122189","volume":"300","author":"T Fang","year":"2023","unstructured":"Fang T, Cao X, Shen B, Chen Z, Chen G. Injectable cold atmospheric plasma-activated immunotherapeutic hydrogel for enhanced cancer treatment. Biomaterials. 2023;300:122189.","journal-title":"Biomaterials"},{"issue":"1","key":"3569_CR22","doi-asserted-by":"publisher","first-page":"7149","DOI":"10.1038\/s41467-022-34791-8","volume":"13","author":"J Svensson-Arvelund","year":"2022","unstructured":"Svensson-Arvelund J, Cuadrado-Castano S, Pantsulaia G, Kim K, Aleynick M, Hammerich L, et al. Expanding cross-presenting dendritic cells enhances oncolytic virotherapy and is critical for long-term antitumor immunity. Nat Commun. 2022;13(1):7149.","journal-title":"Nat Commun"},{"issue":"6","key":"3569_CR23","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.3390\/biomedicines10061243","volume":"10","author":"CB Lee","year":"2022","unstructured":"Lee CB, Lee KI, Kim YJ, Jang IT, Gurmessa SK, Choi EH, et al. Non-thermal plasma jet-treated medium induces selective cytotoxicity against Mycobacterium tuberculosis-infected macrophages. Biomedicines. 2022;10(6):1243.","journal-title":"Biomedicines"},{"issue":"7","key":"3569_CR24","doi-asserted-by":"publisher","first-page":"073702","DOI":"10.1063\/1.4893565","volume":"105","author":"CB Lee","year":"2014","unstructured":"Lee CB, Na YH, Hong T-E, Choi EH, Uhm HS, Baik KY, et al. Evidence of radicals created by plasma in bacteria in water. Appl Phys Lett. 2014;105(7):073702.","journal-title":"Appl Phys Lett"},{"issue":"3","key":"3569_CR25","doi-asserted-by":"publisher","first-page":"101664","DOI":"10.1016\/j.xpro.2022.101664","volume":"3","author":"M Sauter","year":"2022","unstructured":"Sauter M, Sauter RJ, Nording H, Olbrich M, Emschermann F, Langer HF. Protocol to isolate and analyze mouse bone marrow derived dendritic cells (BMDC). STAR Protocols. 2022;3(3):101664.","journal-title":"STAR Protocols"},{"issue":"1","key":"3569_CR26","doi-asserted-by":"publisher","first-page":"9318","DOI":"10.1038\/s41598-018-27473-3","volume":"8","author":"HS Uhm","year":"2018","unstructured":"Uhm HS, Ki SH, Baik KY, Choi EH. Influence of oxygen on generation of reactive chemicals from nitrogen plasma jet. Sci Rep. 2018;8(1):9318.","journal-title":"Sci Rep"},{"key":"3569_CR27","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1063\/1.1748524","volume":"34","author":"D Baulch","year":"2005","unstructured":"Baulch D, Bowman CT, Cobos CJ, Cox RA, Just T, Kerr J, et al. Evaluated kinetic data for combustion modeling: supplement II. J Phys Chem Ref Data. 2005;34:757\u20131397.","journal-title":"J Phys Chem Ref Data"},{"key":"3569_CR28","doi-asserted-by":"publisher","first-page":"966","DOI":"10.3390\/ijms18050966","volume":"18","author":"A Lin","year":"2017","unstructured":"Lin A, Truong B, Patel S, Kaushik N, Choi EH, Fridman G, et al. Nanosecond-pulsed DBD plasma-generated reactive oxygen species trigger immunogenic cell death in A549 lung carcinoma cells through intracellular oxidative stress. Int J Mol Sci. 2017;18:966.","journal-title":"Int J Mol Sci"},{"key":"3569_CR29","doi-asserted-by":"crossref","unstructured":"Orian L, Cozza G, Maiorino M, Toppo S, Ursini F. Glutathione. CRC Press; 2018:53\u2009\u2013\u20097.","DOI":"10.1201\/9781351261760-5"},{"key":"3569_CR30","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.3390\/cancers14102560","volume":"14","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Wang H, Zhou J, Shao Q. Glutathione peroxidase GPX1 and its dichotomous roles in cancer. Cancers. 2022;14:2560.","journal-title":"Cancers"},{"key":"3569_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.dnarep.2015.12.009","volume":"39","author":"A Guleria","year":"2016","unstructured":"Guleria A, Chandna S. ATM kinase: much more than a DNA damage responsive protein. DNA Repair. 2016;39:1\u201320.","journal-title":"DNA Repair"},{"key":"3569_CR32","doi-asserted-by":"crossref","unstructured":"Privat-Maldonado A, Schmidt A, Lin A, Weltmann K-D, Wende K, Bogaerts A et al. ROS from physical plasmas: Redox chemistry for biomedical therapy. Oxid Med Cell Longev. 2019;2019.","DOI":"10.1155\/2019\/9062098"},{"key":"3569_CR33","doi-asserted-by":"publisher","first-page":"103285","DOI":"10.1016\/j.critrevonc.2021.103285","volume":"160","author":"R Malla","year":"2021","unstructured":"Malla R, Surepalli N, Farran B, Malhotra SV, Nagaraju GP. Reactive oxygen species (ROS): critical roles in breast tumor microenvironment. Crit Rev Oncol\/Hematol. 2021;160:103285.","journal-title":"Crit Rev Oncol\/Hematol"},{"key":"3569_CR34","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.canlet.2020.01.019","volume":"474","author":"C-L Kuo","year":"2020","unstructured":"Kuo C-L, Chou H-Y, Chiu Y-C, Cheng AN, Fan C-C, Chang Y-N, et al. Mitochondrial oxidative stress by Lon-PYCR1 maintains an immunosuppressive tumor microenvironment that promotes cancer progression and metastasis. Cancer Lett. 2020;474:138\u201350.","journal-title":"Cancer Lett"},{"issue":"5","key":"3569_CR35","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/nri1604","volume":"5","author":"LC Platanias","year":"2005","unstructured":"Platanias LC. Mechanisms of type-I-and type-II-interferon-mediated signalling. Nat Rev Immunol. 2005;5(5):375\u201386.","journal-title":"Nat Rev Immunol"},{"issue":"6673","key":"3569_CR36","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/32588","volume":"392","author":"J Banchereau","year":"1998","unstructured":"Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature. 1998;392(6673):245\u201352.","journal-title":"Nature"},{"key":"3569_CR37","first-page":"97","volume":"32","author":"Y-F Tan","year":"2010","unstructured":"Tan Y-F, Leong C-F, Cheong S-K. Observation of dendritic cell morphology under light, phase-contrast or confocal laser scanning microscopy. Malays J Pathol. 2010;32:97\u2013102.","journal-title":"Malays J Pathol"},{"key":"3569_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-017-0664-4","volume":"37","author":"H Yang","year":"2018","unstructured":"Yang H, Villani RM, Wang H, Simpson MJ, Roberts MS, Tang M, et al. The role of cellular reactive oxygen species in cancer chemotherapy. J Exp Clin Cancer Res. 2018;37:1\u201310.","journal-title":"J Exp Clin Cancer Res"},{"key":"3569_CR39","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.molmed.2017.03.004","volume":"23","author":"IIC Chio","year":"2017","unstructured":"Chio IIC, Tuveson DA. ROS in cancer: the burning question. Trends Mol Med. 2017;23:411\u201329.","journal-title":"Trends Mol Med"},{"key":"3569_CR40","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.freeradbiomed.2011.11.022","volume":"52","author":"K Pazmandi","year":"2012","unstructured":"Pazmandi K, Magyarics Z, Boldogh I, Csillag A, Rajnavolgyi E, Bacsi A. Modulatory effects of low-dose hydrogen peroxide on the function of human plasmacytoid dendritic cells. Free Radic Biol Med. 2012;52:635\u201345.","journal-title":"Free Radic Biol Med"},{"key":"3569_CR41","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1615\/PlasmaMed.2012006275","volume":"1","author":"H Tanaka","year":"2011","unstructured":"Tanaka H, Mizuno M, Ishikawa K, Nakamura K, Kajiyama H, Kano H, et al. Plasma-activated medium selectively kills glioblastoma brain tumor cells by down-regulating a survival signaling molecule, AKT kinase. Plasma Med. 2011;1:3\u20134.","journal-title":"Plasma Med"},{"issue":"10","key":"3569_CR42","doi-asserted-by":"publisher","first-page":"3945","DOI":"10.1111\/cas.15068","volume":"112","author":"H Nakamura","year":"2021","unstructured":"Nakamura H, Takada K. Reactive oxygen species in cancer: current findings and future directions. Cancer Sci. 2021;112(10):3945\u201352.","journal-title":"Cancer Sci"},{"key":"3569_CR43","doi-asserted-by":"crossref","unstructured":"Yan D, Talbot A, Nourmohammadi N, Sherman JH, Cheng X, Keidar M. Toward understanding the selective anticancer capacity of cold atmospheric plasma\u2014A model based on aquaporins. Biointerphases 2015;10(4).","DOI":"10.1116\/1.4938020"},{"key":"3569_CR44","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0065-2776(07)96002-2","volume":"96","author":"JR Schoenborn","year":"2007","unstructured":"Schoenborn JR, Wilson CB. Regulation of interferon-\u03b3 during innate and adaptive immune responses. Adv Immunol. 2007;96:41\u2013101.","journal-title":"Adv Immunol"},{"key":"3569_CR45","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1158\/1078-0432.CCR-16-0224","volume":"22","author":"M Mandai","year":"2016","unstructured":"Mandai M, Hamanishi J, Abiko K, Matsumura N, Baba T, Konishi I. Dual faces of IFN\u03b3 in cancer progression: a role of PD-L1 induction in the determination of pro-and antitumor immunity. Clin Cancer Res. 2016;22:2329\u201334.","journal-title":"Clin Cancer Res"},{"key":"3569_CR46","doi-asserted-by":"publisher","first-page":"6519","DOI":"10.1158\/0008-5472.CAN-14-0847","volume":"74","author":"B Kharma","year":"2014","unstructured":"Kharma B, Baba T, Matsumura N, Kang HS, Hamanishi J, Murakami R, et al. STAT1 drives tumor progression in serous papillary endometrial cancer. Cancer Res. 2014;74:6519\u201330.","journal-title":"Cancer Res"},{"issue":"1","key":"3569_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1478-811X-10-41","volume":"10","author":"MJ Schmitt","year":"2012","unstructured":"Schmitt MJ, Philippidou D, Reinsbach SE, Margue C, Wienecke-Baldacchino A, Nashan D, et al. Interferon-\u03b3-induced activation of Signal Transducer and activator of transcription 1 (STAT1) up-regulates the tumor suppressing microRNA-29 family in melanoma cells. Cell Communication Signal. 2012;10(1):1\u201314.","journal-title":"Cell Communication Signal"},{"key":"3569_CR48","first-page":"1","volume":"6","author":"J Gong","year":"2018","unstructured":"Gong J, Chehrazi-Raffle A, Reddi S, Salgia R. Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations. JITC. 2018;6:1\u201318.","journal-title":"JITC"},{"key":"3569_CR49","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.immuni.2018.03.014","volume":"48","author":"C Sun","year":"2018","unstructured":"Sun C, Mezzadra R, Schumacher TN. Regulation and function of the PD-L1 checkpoint. Immunity. 2018;48:434\u201352.","journal-title":"Immunity"},{"key":"3569_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-018-0929-6","volume":"37","author":"L Xu","year":"2018","unstructured":"Xu L, Zhang Y, Tian K, Chen X, Zhang R, Mu X, et al. Apigenin suppresses PD-L1 expression in melanoma and host dendritic cells to elicit synergistic therapeutic effects. J Exp Clin Cancer Res. 2018;37:1\u201315.","journal-title":"J Exp Clin Cancer Res"},{"key":"3569_CR51","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.4049\/jimmunol.1004146","volume":"187","author":"D Lakomy","year":"2011","unstructured":"Lakomy D, Janikashvili N, Fraszczak J, Trad M, Audia S, Samson M, et al. Cytotoxic dendritic cells generated from cancer patients. J Immunol. 2011;187:2775\u201382.","journal-title":"J Immunol"},{"key":"3569_CR52","doi-asserted-by":"publisher","first-page":"443","DOI":"10.4049\/jimmunol.1701024","volume":"200","author":"PM Santos","year":"2018","unstructured":"Santos PM, Butterfield LH. Dendritic cell\u2013based cancer vaccines. J Immunol. 2018;200:443\u20139.","journal-title":"J Immunol"},{"issue":"3","key":"3569_CR53","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/cei.12440","volume":"178","author":"F Zhou","year":"2014","unstructured":"Zhou F, Ciric B, Zhang G, Rostami A. Immunotherapy using lipopolysaccharide-stimulated bone marrow-derived dendritic cells to treat experimental autoimmune encephalomyelitis. Clin Exp Immunol. 2014;178(3):447\u201358.","journal-title":"Clin Exp Immunol"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-024-03569-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-024-03569-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-024-03569-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T11:12:21Z","timestamp":1732619541000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancerci.biomedcentral.com\/articles\/10.1186\/s12935-024-03569-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,23]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3569"],"URL":"https:\/\/doi.org\/10.1186\/s12935-024-03569-x","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,23]]},"assertion":[{"value":"27 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Institutional Research and Ethics Committee of Chungnam National University approved all animal experiments (approval number: 202003\u00a0A-CNU-064), which complied with the relevant guidelines of the Korean Food and Drug Administration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"389"}}